Urocit-k and Sinusitis - acute - a phase IV clinical study of FDA data

Summary:

Sinusitis - acute is reported as a side effect among people who take Urocit-k (potassium citrate), especially for people who are female, 60+ old, also take Singulair, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Sinusitis - acute when taking Urocit-k. It is created by eHealthMe based on reports of 648 people who have side effects when taking Urocit-k from the FDA, and is updated regularly.

What is Urocit-k?

Urocit-k has active ingredients of potassium citrate. It is often used in kidney stones. eHealthMe is studying from 708 Urocit-k users. Check the latest studies of Urocit-k.

What is Sinusitis - acute?

Sinusitis - acute is found to be associated with 3,429 drugs and 2,773 conditions by eHealthMe. Check the latest studies of Sinusitis - acute.

On Jul, 11, 2026

648 people reported to have side effects when taking Urocit-k.
Among them, 25 people (3.86%) have Sinusitis - acute.

Among these 25 people:

What is the gender of people who have Sinusitis - acute when taking Urocit-k? *

female: 80 %
male: 20 %

What is the age of people who have Sinusitis - acute when taking Urocit-k? *

What are other drugs people take besides Urocit-k? *

What are other side effects people have besides Sinusitis - acute? *

Head Injury: 11 people, 44.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 10 people, 40.00%
Systemic Mycosis (fungal infections of the body): 8 people, 32.00%
Weight Decreased: 7 people, 28.00%
Fall: 7 people, 28.00%
Spinal Compression Fracture (fracture due to spinal compression on bone): 6 people, 24.00%
Wrist Fracture: 6 people, 24.00%
Heart Attack: 5 people, 20.00%
Fatigue (feeling of tiredness): 3 people, 12.00%
Drug Hypersensitivity: 2 people, 8.00%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 16 people, 64.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.00%
Pain: 2 people, 8.00%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 8.00%
Vulvovaginal Pruritus (vulvovaginal severe itching): 1 person, 4.00%
Dizziness: 1 person, 4.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 4.00%
B-Lymphocyte Abnormalities (abnormal population of b lymphocytes in the blood, bone marrow, or tissues): 1 person, 4.00%
Back Pain: 1 person, 4.00%
Bladder Cancer: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Urocit-k and have Sinusitis - acute?

- Check whether Sinusitis - acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Urocit-k:

Urocit-k (708 reports)

Sinusitis - acute treatments and more:

Sinusitis - acute (153,485 reports)

Browse all side effects of Urocit-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - acute:

Sinusitis - acute (3,429 drugs)

Browse all the conditions that are associated with Sinusitis - acute:

Sinusitis - acute (2,773 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium citrate (the active ingredients of Urocit-k) and Urocit-k (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.